A A A
-->

2016

Originals

  1. Müller S, Rafei-Shamsabadi D, Technau K, Renzel S, Jakob T. Bullous deplayed pressure urticaria responding to omalizumab. Acta Derm Venerol 96: 416–417, 2016 IF: 3.678
  2. Pföhler C, Müller CSL, Dorn B, Jakob T, Vogt T. Contact anaphylaxis after application of an herbal ointment containing phenonip, Allergo J Int 25:64-66, 2016 IF 0,0
  3. Dhami S, Nurmatov U, Varga EM, Sturm G, Muraro A, Akdis CA, Antolín-Amérigo D, Bilò MB, Bokanovic D, Calderon MA, Cichocka-Jarosz E, Elberink JN, Gawlik R, Jakob T, Kosnik M, Lange J, Mingomataj E, Mitsias DI, Mosbech H, Pfaar O, Pitsios C, Pravettoni V, Roberts G, Ruëff F, Sin BA, Sheikh A. Allergen immunotherapy for insect venom allergy: protocol for a systematic review. Clin Transl Allergy 6:6, 2016. doi: 10.1186/s13601-016-0095-x IF 0,0
  4. Bantleon F, Wolf S, Seismann H, Dam S, Lorentzen A, Miehe M, Jabs F, Jakob T, Plum M, Spillner E. Human IgE is efficiently produced in glycosylated and biologically active form in lepidopteran cells. Mol Immunol. 72:49-56, 2016 doi: 10.1016/j.molimm.2016.02.013. IF 3.375
  5. Kespohl S, Maryska S, Bünger J, Hagemeyer O, Jakob T, Joest M, Knecht R, Koschel D, Kotschy-Lang N, Merget R, Mülleneisen NK, Rabe U, Röseler S, Sander I, Stollewerk D, Straube H, Ulmer HM, van Kampen V, Walusiak-Skorupa J, Wiszniewska M, Wurpts G, Brüning T, Raulf M. How to diagnose mould allergy? Comparison of skin prick tests with specific IgE results. Clin Exp Allergy Clin Exp Allergy 46:981-91. doi: 10.1111/cea.12733 IF 587
  6. Has C, Schwieger-Briel A, Schlipf N, Hausser I, Chmel N, Rösler B, Technau K, Jakob T, Zimmer A, Fischer J Target-sequence capture and high throughput sequencing identify a de novo CARD14 mutation in an infant with erythrodermic pityriasis rubra pilaris. Acta Derm Venerol 96:989-990; 2016 doi: 10.2340/00015555-2446 IF3.678
  7. Bilò MB, Cichocka-Jarosz E, Pumphrey R, Oude-Elberink JN, Lange J, Jakob T ,Bonadonna P, Fernandez J, Kosnik M, Helbling A, Mosbech H, Gawlik R, Niedoszytko M, Patella V, Pravettoni V, Rodrigues-Alves R, Sturm GJ, Rueff F. Self-medication of anaphylactic reactions due to Hymenoptera stings – An EAACI Task Force Consensus Statement. Allergy 71:931-43; 2016. doi: 10.1111/all.12908 IF 6.335
  8. Kumar V, Behr M, Kiritsi D, Scheffschick A, Grahnert A, Homberg M, Schwieger-Briel A, Jakob T, Bruckner-Tuderman L, Magin TM. Keratin-dependent TSLP expression suggests a link between skin blistering and atopic disease. J Allergy Clin Immunol 138:1461-1464.e6; 2016 doi: 10.1016/j.jaci.2016.04.046 IF 12.485
  9. Frick M, Fischer J, Helbling A, Rueff F, Wieczorek D, Ollert M, Pfützner W, Müller S, Huss-Marp J Dorn B, Biedermann T, Lidholm J, Ruecker G, Bantleon F, Mühe M, Spillner E, Jakob T. Predominant Api m 10 sensitization as risk factor for treatment failure in honey bee venom immunotherapy. J Allergy Clin Immunol 138:1663–1671.e9; 2016 doi: 10.1016/j.jaci.2016.04.024 IF 12.485
  10. Kunz S, Dolch A, Dorn B, Bewersdorff M, Alessandrini F, Surianarayanan S, Behrendt R, Karp CL, Mueller W, Martin SF, Roers A, Jakob T. T cell derived interleukin 10 is dispensable for tolerance induction in a murine model of specific immunotherapy. Eur J Immunol. 46:2018-27; 2016 doi: 1002/eji.201646319 IF 4.179
  11. Brockow K, Beyer K, Biedermann T, Fischer J, Gieler U, Giessler-Fichtner O, Gebert N, Jakob T, Klimek L, Kugler C, Reese I, Rietschel E, Ruëff F, Schnadt S, Siemens C, Szczepanski R, Worm M, Ring J, Lange L. Supportive care of patients with anaphylaxis – treatment options and shortcomings: an assessment on behalf of the working group on anaphylaxis training and education (AGATE), Germany. Allergo J Int 25:160–8, 2016 IF 0,0
  12. Schaller M, Schöfer H, Homey B, Hofmann M, Gieler U, Lehmann P, Luger TA, Ruzicka T, Steinhoff M.(2016) Schaller M, Schöfer H, Homey B, Hofmann M, Gieler U, Lehmann P, Luger TA, Ruzicka T (2016) Rosacea Management: Update on general measures and topical treatment options. J Dtsch Dermatol Ges. 14 Suppl 6:17-27. IF 2.511
  13. Reinholz M, Ruzicka T, Steinhoff M, Schaller M, Gieler U, Schöfer H, Homey B, Lehmann P, Luger TA. (2016) Pathogenesis and clinical presentation of rosazea as a key for a symptom-oriented therapy. J Dtsch Dermatol Ges.14 Suppl 6:4-15 IF 2.511
  14. Schaller M, Schöfer H, Homey B, Gieler U, Lehmann P, Luger TA, Ruzicka T, Steinhoff M.(2016) State of the art: systemic rosacea management. J Dtsch Dermatol Ges. 14 Suppl 6:29-37. 2.511
  15. Sampogna F, Abeni D, Gieler U, Tomas-Aragones L, Lien L, Titeca G, Jemec GB, Misery L, Szabó C, Linder MD, Evers AW, Halvorsen JA, Balieva F, Szepietowski JC, Romanov DV, Marron SE, Altunay IK, Finlay AY, Salek SS, Kupfer J, Dalgard F (2016) Impairment of Sexual Life in 3,485 Dermatological Outpatients From a Multicentre Study in 13 European Countries. Acta Derm Venereol. Nov 7. doi: 10.2340/00015555-2561. 3.678
  16. Tomas-Aragones L, Consoli SM, Consoli SG, Poot F, Taube KM, Linder MD, Jemec GB, Szepietowski JC, Korte J, Lvov AN, Gieler U (2016) Self-Inflicted Lesions in Dermatology: A Management and Therapeutic Approach - A Position Paper From the European Society for Dermatology and Psychiatry. Acta Derm Venereol. Aug 26. doi: 10.2340/00015555-2522. IF 3.678
  17. Linder MD, Piaserico S, Augustin M, Fortina AB, Cohen AD, Gieler U, Jemec GB, Kimball AB, Peserico A, Sampogna F, Warren RB, de Korte J (2016) Psoriasis - The Life Course Approach. Acta Derm Venereol. Aug 23;96(217):102-108. IF3.678
  18. Lahousen T, Kupfer J, Gieler U, Hofer A, Linder MD, Schut C. Differences Between Psoriasis Patients and Skin-healthy Controls Concerning Appraisal of Touching, Shame and Disgust. Acta Derm Venereol. 23;96(217):78-82; 2016. IF 3.678
  19. Schut C, Rädel A, Frey L, Gieler U, Kupfer J. Role of personality and expectations for itch and scratching induced by audiovisual itch stimuli. Eur J Pain. 20(1):14-8. 2016 IF 2.9
  20. Heppt MV, Eigentler TK, Kähler KC, Herbst RA, Göppner D, Gambichler T, Ulrich J, Dippel E, Loquai C, Schell B, Schilling B, Schäd SG, Schultz ES, Matheis F, Tietze JK, Berking C. Immune checkpoint blockade with concurrent electrochemotherapy in advanced melanoma: a retrospective multicenter analysis. Cancer Immunol Immunother. 2016 Aug;65(8):951-9. doi: 10.1007/s00262-016-1856-z. IF 4.846
  21. Hofmann L, Forschner A, Loquai C, Goldinger SM, Zimmer L, Ugurel S, Schmidgen MI, Gutzmer R, Utikal JS, Göppner D, Hassel JC, Meier F, Tietze JK, Thomas I, Weishaupt C, Leverkus M, Wahl R, Dietrich U, Garbe C, Kirchberger MC, Eigentler T, Berking C, Gesierich A, Krackhardt AM, Schadendorf D, Schuler G, Dummer R, Heinzerling LM. Cutaneous, gastrointestinal, hepatic, endocrine, and renal side-effects of anti-PD-1 therapy. Eur J Cancer. 2016 Jun;60:190-209. doi: 10.1016/j.ejca.2016.02.025. IF 6.163
  22. Zimmer L, Goldinger SM, Hofmann L, Loquai C, Ugurel S, Thomas I, Schmidgen MI, Gutzmer R, Utikal JS, Göppner D, Hassel JC, Meier F, Tietze JK, Forschner A, Weishaupt C, Leverkus M, Wahl R, Dietrich U, Garbe C, Kirchberger MC, Eigentler T, Berking C, Gesierich A, Krackhardt AM, Schadendorf D, Schuler G, Dummer R, Heinzerling LM. Neurological, respiratory, musculoskeletal, cardiac and ocular side-effects of anti-PD-1 therapy. Eur J Cancer. 2016 Jun;60:210-25. doi: 10.1016/j.ejca.2016.02.024. IF: 6.163

 

Reviews

 

  1. Werfel T, Heratizadeh A, Aberer W, Ahrens F, Augustin M, Biedermann T, Diepgen T, Fölster-Holst R, Gieler U, Kahle J, Kapp A, Nast A, Nemat K, Ott H, Przybilla B, Roecken M, Schlaeger M, Schmid-Grendelmeier P, Schmitt J, Schwennesen T, Staab D, Worm M (2016) S2k guideline on diagnosis and treatment of atopic dermatitis - short version. Allergo J Int. 2016;25:82-95. IF 0,0
  2. Werfel T, Heratizadeh A, Aberer W, Ahrens F, Augustin M, Biedermann T, Diepgen T, Fölster-Holst R, Gieler U, Kahle J, Kapp A, Nast A, Nemat K, Ott H, Przybilla B, Roecken M, Schlaeger M, Schmid-Grendelmeier P, Schmitt J, Schwennesen T, Staab D, Worm M (2016) S2k guideline on diagnosis and treatment of atopic dermatitis--short version. J Dtsch Dermatol Ges. 14(1):92-106. IF 511
  3. Bieber T, Akdis C, Lauener R, Traidl-Hoffmann C, Schmid-Grendelmeier P, Schäppi G, Allam JP, Apfelbacher C, Augustin M, Beck L, Biedermann T, Braun-Fahrländer C, Chew FT, Clavel T, Crameri R, Darsow U, Deleuran M, Dittlein D, Duchna HW, Eichenfeld L, Eyerich K, Frei R, Gelmetti C, Gieler U, Gilles S, Glatz M, Grando K, Green J, Gutermuth J, Guttman-Yassky E, Hanifin J, Hijnen D, Hoetzenecker W, Irvine A, Kalweit A, Katoh N, Knol E, Koren H, Möhrenschlager M, Münch D, Novak N, O'Mahony L, Paller AS, Rhyner C, Roduit C, Schiesser K, Schröder J, Simon D, Simon HU, Sokolowska M, Spuls P, Stalder JF, Straub D, Szalai Z, Taieb A, Takaoka R, Todd G, Todorova A, Vestergaard C, Werfel T, Wollenberg A, Ring J (2016) Global Allergy Forum and 3rd Davos Declaration 2015: Atopic Dermatitis/Eczema: challenges and opportunities toward precision medicine. Allergy. 71(5):588-92. IF 6.335
  4. Tomas-Aragones L, Gieler U, Linder DM. FRONTIERS IN PSYCHOCUTANEOUS DISEASES: Selected Writings in Psychosomatics, Psychodermatology and Psycho-Neuro-Endocrinoimmunology. A Memorial Publication for Emiliano Panconesi. Acta Derm Venereol. 96(Suppl. 217):1-152, 2016 IF 3.678
  5. Schut C, Mollanazar NK, Kupfer J, Gieler U, Yosipovitch G. Psychological Interventions in the Treatment of Chronic Itch. Acta Derm Venereol. 96(2):157-161, 2016 IF 3.678
  6. Evers AW, Schut C, Gieler U, Spillekom-van Koulil S, van Beugen S (2016) Itch management: Psychotherapeutic Approach. Curr Probl Dermatol. 50:64-70, 2016, IF 0.0
  7. EAACI Molecular Allergology User's Guide. Matricardi PM, Kleine-Tebbe J, Hoffmann HJ, Valenta R, Hilger C, Hofmaier S, Aalberse RC, Agache I, Asero R, Ballmer-Weber B, Barber D, Beyer K, Biedermann T, Bilò MB, Blank S, Bohle B, Bosshard PP, Breiteneder H, Brough HA, Caraballo L, Caubet JC, Crameri R, Davies JM, Douladiris N, Ebisawa M, EIgenmann PA, Fernandez-Rivas M, Ferreira F, Gadermaier G, Glatz M, Hamilton RG, Hawranek T, Hellings P, Hoffmann-Sommergruber K, Jakob T, Jappe U, Jutel M, Kamath SD, Knol EF, Korosec P, Kuehn A, Lack G, Lopata AL, Mäkelä M, Morisset M, Niederberger V, Nowak-Węgrzyn AH, Papadopoulos NG, Pastorello EA, Pauli G, Platts-Mills T, Posa D, Poulsen LK, Raulf M, Sastre J, Scala E, Schmid JM, Schmid-Grendelmeier P, van Hage M, van Ree R, Vieths S, Weber R, Wickman M, Muraro A, Ollert M. EAACI Molecular Allergology User's Guide. Pediatr Allergy Immunol. 2016 May;27 Suppl 23:1-250. doi: 10.1111/pai.12563. IF 3.947

Editorials

  1. Gieler U (2016) Allergie und Psyche; Allergologie
  2. Gieler U, Tomas-Aragones L, Linder DM Emiliano Panconesi Memorial. Acta Derm Venereol. 96 (Suppl. 217):1, 2016
  3. Merk H, Jakob T. Vorsicht: Verwirrspiel bei SIT Präparaten. Editorial Allergo J 25(2):3, 2016
  4. Jakob T, Merk H. Licht ins Dunkel der Therapieallergeneverordnung, Editorial Allergo J 25(3):3, 2016
  5. Merk H, Jakob T. Der Stellenwert von In-vitro-Testungen. Allergo J 25(4):3, 2016
  6. Jakob T, Merk H. Verbandsarbeit trägt Früchte. Editorial Allergo J 25(5):3, 2016
  7. Merk H, Jakob T. Allergologie in Tiefe und Breite. Editorial Allergo J 25(6):3, 2016
  8. Jakob T, Merk H. AEDA und DGAKI im Schulterschluss. Editorial Allergo J 25(7):3, 2016
  9. Merk H, Jakob T. Biologika halten Einzug in die Allergologie. Editorial Allergo J 25(8):3, 2016

 

Book Chapters

  1. Taube KM, Rapp G, Seikowski K, Gieler U (2016) Die Haut und die Sprache der Seele. Fischer & Gann Verlag Wien-Wiesbaden